CIK 0001650664
- Non-accelerated filer
- Smaller reporting company
Editas Medicine, Inc.
Sign in to watch- Ticker
- EDIT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 464097528
- Phone
- +1 617-401-9000
- Business address
- 11 HURLEY ST., CAMBRIDGE, MA, 02141
- 4 Grant or award CEO acquired 50,000 shares (grant or award)
- 4 Open-market sale EVP, CBO AND CTO sold 101 shares at $8.89 ($898)
- 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 2,790 shares at $9.67 ($26,966)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 4,287 shares at $9.67 ($41,435)
- 4 Open-market sale EVP, CBO AND CTO sold 3,307 shares at $9.67 ($31,963)
- 4 Open-market sale EVP, CBO AND CTO sold 346 shares at $11.10 ($3,841)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,752 shares at $8.16 ($14,296)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 193 shares at $10.23 ($1,974)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 102 shares at $10.23 ($1,043)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 289 shares at $11.02 ($3,185)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 192 shares at $15.01 ($2,882)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 101 shares at $15.01 ($1,516)
- 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 293 shares at $18.60 ($5,449)
- 4 Grant or award SVP, CHIEF MEDICAL OFFICER acquired 58,372 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,145 shares at $10.06 ($51,745)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 6 of 18 · 351 filings